Skandinaviska Enskilda Banken (SEB)’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.87M | Buy |
|
|||||
|
2025
Q1 | $5.48M | Hold |
|
|||||
|
2024
Q4 | $5.08M | Buy |
|
|||||
|
2024
Q3 | $4.21M | Sell |
|
|||||
|
2024
Q2 | $5.42M | Hold |
|
|||||
|
2024
Q1 | $5.75M | Buy |
|
|||||
|
2023
Q4 | $6.13M | Sell |
|
|||||
|
2023
Q3 | $10.1M | Sell |
|
|||||
|
2023
Q2 | $17.3M | Buy |
|
|||||
|
2023
Q1 | $19.4M | Buy |
|
|||||
|
2022
Q4 | $19.9M | Buy |
|
|||||
|
2022
Q3 | $6.38M | Sell |
|
|||||
|
2022
Q2 | $6.63M | Sell |
|
|||||
|
2022
Q1 | $6.37M | Sell |
|
|||||
|
2021
Q4 | $7.74M | Buy |
|
|||||
|
2021
Q3 | $6.05M | Buy |
|
|||||
|
2021
Q2 | $6.46M | Sell |
|
|||||
|
2021
Q1 | $6.76M | Sell |
|
|||||
|
2020
Q4 | $8.96M | Buy |
|
|||||
|
2020
Q3 | $7.46M | Buy |
|
|||||
|
2020
Q2 | $7.71M | Sell |
|
|||||
|
2020
Q1 | $6.58M | Sell |
|
|||||
|
2019
Q4 | $9.75M | Buy |
|
|||||
|
2019
Q3 | $7.18M | Sell |
|
|||||
|
2019
Q2 | $9.21M | Sell |
|
|||||
|
2019
Q1 | $10.9M | Buy |
|
|||||
|
2018
Q4 | $5.65M | Sell |
|
|||||
|
2018
Q3 | $7.82M | Sell |
|
|||||
|
2018
Q2 | $9.47M | Buy |
|
|||||
|
2018
Q1 | $7.56M | Buy |
|
|||||
|
2017
Q4 | $4.17M | Buy |
|
|||||
|
2017
Q3 | $4.29M | Sell |
|
|||||
|
2017
Q2 | $4.44M | Sell |
|
|||||
|
2017
Q1 | $4.99M | Sell |
|
|||||
|
2016
Q4 | $5.11M | Sell |
|
|||||
|
2016
Q3 | $6.33M | Sell |
|
|||||
|
2016
Q2 | $5.66M | Sell |
|
|||||
|
2016
Q1 | $6.16M | Sell |
|
|||||
|
2015
Q4 | $7.87M | Buy |
|